EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

A Personalized, Texting-Based Conversational Agent to Address Sleep Disturbance in Individuals Who Have Survived Breast Cancer: Protocol for a Pilot Waitlist Randomized Controlled Trial

Chi-Shan Tsai iD, Warren Szewczyk iD, Michelle Drerup iD, Jason Liao iD, Alexi Vasbinder iD, Heather Greenlee iD, Jaimee L Heffner iD, Rachel Yung iD, Kerryn W Reding iD

JMIR Research Protocols · 2025

DOI: 10.2196/62712 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, 2025. Written by Chi-Shan Tsai and 8 co-authors. Institution: School of Nursing, University of Washington, Seattle, WA, United States. Major MEDLINE topics: Text Messaging, Breast Neoplasms, Cancer Survivors, Cognitive Behavioral Therapy. Cited 3 times so far (Crossref); 38 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Sleep disturbance is one of the most common health concerns reported by individuals who have survived breast cancer (BC) and is associated with poor quality of life (QoL) and greater mortality after treatment. Cognitive behavioral therapy for insomnia (CBTi) has shown efficacy for improving sleep and QoL for this population. Considered the gold standard for insomnia treatment, CBTi can be delivered remotely, including via digital intervention. Despite the potential for wider dissemination of CBTi via digital means, these modalities have unique challenges, including technology barriers and poor adherence. We developed a conversational agent (CA) to deliver CBTi via a SMS text messaging intervention, supported by mobile-ready web content. Named “Cecebot,” this CA delivers sleep education, implements sleep compression, provides just-in-time interventions for sleep-disrupting behaviors, and includes enhanced support for physical activity (PA) beyond what is typically included in CBTi. This represents a novel modality for a CBTi and PA intervention among individuals who have survived BC.

Objective

We aim to examine the safety and acceptability of the Cecebot intervention, developed by an academic partnership between Dr Reding’s research team and Moby Inc, for individuals who have survived BC and experience symptoms of insomnia, and to explore its efficacy.

Methods

This trial will recruit 60 individuals who have survived BC and are experiencing moderate to severe sleep disturbance. Participants will be assigned to the Cecebot intervention or waitlist control group at a 1:1 ratio. The treatment group will receive the Cecebot intervention during weeks 1-6 of the study, while the waitlist control condition will receive the Cecebot intervention during weeks 6-12. The Cecebot intervention uses SMS text messaging technology paired with a Fitbit. Participants will be assessed at baseline, week 6, and week 12. Measurements will include feasibility and acceptability and will explore the effect of the Cecebot intervention. Feasibility will be assessed through recruitment, enrollment, and retention rates. Acceptability will be evaluated using a satisfaction survey and open-ended responses. Quantitative analysis, such as t test, Fisher exact tests, and generalized linear models, will be used to assess feasibility, baseline group differences, and the outcomes of the intervention.

Results

Recruitment of participants began in Fall 2024. The completion of data collection is anticipated to be by Fall 2025.

Conclusions

The study results will give insight into the potential for an SMS text messaging–based CA to improve sleep in individuals who have survived BC and experience sleep disturbances. Trial Registration ClinicalTrials.gov NCT06392789; https://clinicaltrials.gov/study/NCT06392789 International Registered Report Identifier (IRRID) DERR1-10.2196/62712

Subjects

MeSH terms (MEDLINE)

Text MessagingBreast NeoplasmsCancer SurvivorsCognitive Behavioral TherapySleep Initiation and Maintenance DisordersSleep Wake DisordersHumansFemalePilot ProjectsQuality of LifeAdultRandomized Controlled Trials as TopicMiddle Aged

Author keywords

breast cancercognitive behavioral therapy for insomniaconversational agentphysical activityrandomized controlled trialsleep disturbance

Authors and institutions

  • School of Nursing, University of Washington, Seattle, WA, United States.
  • School of Public Health, University of Washington, Seattle, WA, United States.
  • Neurological Insititute, Cleveland Clinic, Cleveland, OH, United States.
  • Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • School of Medicine, University of Washington, Seattle, WA, United States.

ORCID profiles: Chi-Shan Tsai, Warren Szewczyk, Michelle Drerup, Jason Liao, Alexi Vasbinder, Heather Greenlee, Jaimee L Heffner, Rachel Yung, Kerryn W Reding

Cite

APA

Tsai, C. S., Szewczyk, W., Drerup, M., Liao, J., Vasbinder, A., Greenlee, H., Heffner, J. L., Yung, R., & Reding, K. W. (2025). A Personalized, Texting-Based Conversational Agent to Address Sleep Disturbance in Individuals Who Have Survived Breast Cancer: Protocol for a Pilot Waitlist Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/62712

Vancouver

Tsai CS, Szewczyk W, Drerup M, Liao J, Vasbinder A, Greenlee H, et al. A Personalized, Texting-Based Conversational Agent to Address Sleep Disturbance in Individuals Who Have Survived Breast Cancer: Protocol for a Pilot Waitlist Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/62712

BibTeX
@article{Tsai2025,
  author = {Tsai, Chi-Shan and Szewczyk, Warren and Drerup, Michelle and Liao, Jason and Vasbinder, Alexi and Greenlee, Heather and Heffner, Jaimee L and Yung, Rachel and Reding, Kerryn W},
  title = {A Personalized, Texting-Based Conversational Agent to Address Sleep Disturbance in Individuals Who Have Survived Breast Cancer: Protocol for a Pilot Waitlist Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/62712}
}
Start for free →